REHOBOTH GLOBAL LTDActive

Company number 11277104Private limited companyIncorporated 2018

Key figures

£2,203+1,594.6%
Net assets 2024/25
+69.6%
Average annual growth 2020/21–2024/25
01 k2 k3 k2020/212021/222022/232023/242024/25

Like most small UK companies, REHOBOTH GLOBAL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 k5 k7.5 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand12211—293202
Total assets6,1664,8253,6142,5963,741
Total liabilities6,4324,6263,6332,4661,538
Net assets / total equity266199191302,203
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Principal activity of the company during the financial year was of Pharmacy Services

As described in the company's latest filed accounts.

Summary: REHOBOTH GLOBAL LTD

Company

REHOBOTH GLOBAL LTD is a private limited company registered with Companies House under company number 11277104. It was incorporated on 27 Mar 2018. Its status is active. The registered office is in Manchester (M38). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £2,203, up 1,594.6% on the previous year. Cash at bank and in hand was £202. Total assets were £3,741 and total liabilities £1,538. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 9 Apr 2027.